Quince Therapeutics (QNCX) said Friday it has changed its name to IRulya Therapeutics, effective later today.
The company said its stock will begin trading on the Nasdaq Capital Market under the "IRLA" ticker on Monday.
The name change follows the completion of Quince's merger with Orphai Therapeutics, the company said.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.